Амин кислотасы протеинны синтезлау өчен кулланыла
Продукция җентекты
| NO | Продуктлар | CAP NOК | Сыйфатлы сыйфат күрсәткече | |||
| Чисталык | Макс. пычраклык | Гомуми калдык калдыклары | Дым | |||
| 1 | Fmoc-β-Ala-AH OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 2 | Fmoc-d-aa-d-Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 3 | Fmoc-β-Ala-d-Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 4 | FMOC-ARG (ПБФ)-марГ (ПБФ) -АБ | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 5 | Fmoc-β-Ала-Арг (ПБФ) --oH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 6 | FMOC-D-ARG (ПБФ) -D-ARG (ПБФ) - Ооль | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 7 | FMOC-β-Ala-D-ARG (ПБФ) - Ооль | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 8 | Fmoc-homoarg (ПБФ) - Гомоарг (ПБФ) - Ооль | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 9 | FMoc-β-Al-Al-HomoarG (ПБФ) --oH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 10 | Fmoc-asn (trt)-пастан (trt) --oH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 | Fmoc-β-Ала-АСН (TRT) --OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 12 | FMOC-ASP (OTBU)-пассп (ОТбу) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 13 | FMOC-β-Ала-ASP (ОТбу) --OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 14 | Fmoc-cys (trt) - уллар (trt) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 15 | Fmoc-β-Ala-Cys (trt) -ОС | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 16 | Fmoc-cys (ACM) --Си (ACM) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 17 | Fmoc-β-Ala-Cys (ACM) --oH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 18 | Fmoc-gln (trt) -Глн (trt) -Глн | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 19 | Fmoc-β-Ала-глн (trt) --OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 20 | FMOC-GLU (ОТбу) - ТМЛу (ОТбу) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 21 | Fmoc-β-Ala-glu (ОТбу) -OH.h2o | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 22 | Fmoc-β-Ала-Гли-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 23 | ФМок-аның (trt) - гис (trt) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 24 | Fmoc-β-Ала-аның (trt) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 25 | Fmoc-ile-ile-eh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 26 | Fmoc-β-Ala-ILE-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 27 | Fmoc-leu-leu-eh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 28 | Fmoc-β-Ala-leu-eh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 29 | Fmoc-d-leu-d-leu-eh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 30 | Fmoc-β-Ала-д-леу-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 31 | Fmoc-lys (BOC) -LYS (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 32 | FMoc-β-AlaS (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 33 | Fmoc-lys (аллок) -лар (аллада) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 34 | Fmoc-β-AliS (аллада) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 35 | FMoc-Met-Met-Met | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 36 | Fmoc-β-Алан-мета-эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 37 | Fmoc-Orn (BOC) -Корнор (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 38 | Fmoc-β-Aln (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 39 | Fmoc-phe-phe-eh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 40 | Fmoc-β-Ala-Phe-eh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 41 | Fmoc-d-phe-d-phe-eh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 42 | Fmoc-β-Ala-d-Phe-Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 43 | Fmoc-pro-Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 44 | Fmoc-β-Ala-pro-Oh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 45 | Fmoc-ser (tbu)-сер (туб) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 46 | FMOC-β-Ala-Ser (TBU) --oH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 47 | Fmoc-ser (trt)-сер (trt)-сер | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 48 | Fmoc-β-Ала-сер (trt) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 49 | Fmoc-thuc (tbu)-Крыгыз (TBU) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 50 | Fmoc-β-Ala--threv (TBU) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 51 | Fmoc-trp (boc) -Т (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 52 | Fmoc-β-Alal trp (BOC) --OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 53 | FMoc-D-Trp (BOC) -D TRP (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 54 | FMoc-β-Ala-D-Trp (BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 55 | Fmoc-tyr (tbu) - atter (tbu) - | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 56 | FMOC-β-Aala-TYR (TBU) --oH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 57 | Fmoc-d-Tyr (ET) -D-TYR (ET) -Д | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 58 | FMoc-β-Ala-D-Tyr (et) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 59 | Fmoc-tyr (мин) - attyr | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 60 | FMOC-β-Ala-Tyr (Мине) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 61 | Fmoc-val-val-eh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 62 | Fmoc-β-Ала-вал-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 63 | FMoc-D-Cit-D-EH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 64 | FMoc-β-Ala-D-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 65 | Fmoc-β-Ала-Даб-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 66 | FMOC- (3- (2-НафтХутил) -D-AD) 2-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 67 | Fmoc-β-Alal 3- (2-Нафтил) -D-Ала-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 68 | Fmoc- (3- (3-Пиридинил) -Д-Ала) 2-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 69 | Fmoc-β-Alal 3- (3-Пиридинил) -D-Ала-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 70 | Fmoc- (4-хлоро-д-пре) 2-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 71 | FMOC-β-Ala-4-Chloro-D-Phe-OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 72 | Fmoc- (d-4ph (tbucbm) 2-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 73 | FMOC-β-Ala-D-4aPH (TBUCBM)-4 | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 74 | Fmoc-aph (L-hor) -АФ (л-хр) --OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 75 | Fmoc-β-Ала-Аче (L-HOR) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 76 | Fmoc-lys (ipr, boc) -Les (ipr, boc) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 77 | FMoc-β-AliS (IPR, BOC) -OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 78 | Fmoc-β-Ала-Айа-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 79 | Fmoc-AIB-AIB-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 80 | Fmoc-β-Ала-Ай-Айби-Эх | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 81 | Fmoc-arg-eh | 91000-69-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 82 | H-ARG (ПБФ) - Ооль | 200115-86-2 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 83 | Fmoc-d-arg-eh | 130752-32-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 84 | HD-Arg (ПБФ) - Ооль | 200116-81-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 85 | Fmoc-homoarg-oh.h.cc | 208174-14-5 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 86 | H-HoMoarG (ПБФ)-ХИСС | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 87 | Fmoc-d-homoarg-eh | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 88 | Hd-homoarg (ПБФ) --oH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 89 | Fmoc-asn-eh | 71989-16-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 90 | H-ASN (trt) | 132388-58-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 91 | Fmoc-asp-eh | 119062-05-4 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 92 | H-ASP (ОТбу) -OHOOH | 3057-74-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 93 | Fmoc-cys-eh | 135248-89-4 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 94 | H-cys (trt)- | 2799/7/7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 95 | H-CYS (ACM) -OHCL | 28798-28-9 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 96 | Fmoc-glun-eh | 71989-20-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 97 | H-Gln (trt)-глн | 102747-84-2 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 98 | Fmoc-glu-eh | 121343-82-6 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 99 | H-glu (ОТбу) Oh.h2o | 2419-56-9 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 100 | Fmoc-he oh | 116611-64-4 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 101 | H-аның (trt) | 35146-32-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 102 | Бок-аның-Эх | 17791-52-5 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 103 | Fmoc-lys-eh | 105047-45-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 104 | H-lys (BOC) --OH | 2418-95-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 105 | H-lys (аллада) | 6298/3/9 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 106 | Fmoc-Orn-Oh.h.cc | 201046-57-3-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 107 | H-Orn (BOC) -OH | 13650-49-2 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 108 | Fmoc-ser-eh | 73724-45-5-5 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 109 | H-ser (tbu)-сер | 18822-58-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 110 | H-ser (trt) -OHOOH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 111 | Fmoc-hu-oh.h2o | 73731-37-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 112 | H-thr (tbu )oh | 4378-13-6 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 113 | Fmoc-trp-eh | 35737-15-6 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 114 | H-TRP (BOC) -OHOOH | 146645-63-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 115 | Fmoc-d-trp-eh | 86123-11-7 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 116 | HD-TRP (BOC) -OHOOH | 201290-11-1 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 117 | Fmoc-tyr-eh | 92954-90-0 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 118 | H-Tyr (TBU) | 18822-59-8 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 119 | Fmoc-d-tyr-eh | 112883-29-1 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 120 | Hd-tyr (et) | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 121 | H-tyr (мин) -OHCL | 67423-44-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 122 | Fmoc-d-4aph (cbm) -oH | 324017-22-3-3 | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 123 | Hd-4ph (tbucbm) -Бо | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 124 | Fmoc-lys (ipr) -oH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 125 | H-lys (irph, BOC) --OH | NA | ≥98,0% | ≤1.0% | ≤8.0% | ≤2.0% |
Турында
Компенсация
GetLolex зур сыйфатлы продуктлар белән тәэмин итә, әгәр җитәрлек дәлилләр кирәкле вакыт эчендә кирәкле вакыт эчендә, компенсация процедураларын уяту өчен кирәкле анализ һәм бәя бирәчәкбез.
Җитештерү
Фармацевтика продуктларының мөмкинлекләре, тоннага ирешкән мөмкинлекләр, химия продуктларының мөмкинлекләре - бу дөнья буенча клиентларга хезмәт итәр өчен яхшы җиһазландырылган.
Тикшеренүләр һәм үсеш
Ел саен, төрле яңа продуктлар төзү өчен, R & D командасы куелган план бар, максатлар җыелганда, командадагы һәр әгъзаны KPI җаваплылыгын һәм стимул политикасы белән дәвам итәргә тиеш.
